Felix J. Baker, Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Felix J. Baker, Ph.D.
Felix J. Baker, Ph.D. is recorded as Board Member at Kymera Therapeutics, Inc. (KYMR). Kymera Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Felix J. Baker, Ph.D. was appointed Lead Independent Director, effective March 28, 2024. Kymera Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Felix J. Baker, Ph.D. was appointed Class II director, effective March 28, 2024.
“Dr. Baker was also appointed to serve as the Lead Independent Director of the Board.”
“On March 28, 2024, upon the recommendation of the Nominating and Corporate Governance Committee of the Board of Directors (the "Board") of Kymera Therapeutics, Inc. (the "Company"), the Board appointed Felix J. Baker, Ph.D. to join the Board, effective March 28, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kymera Therapeutics, Inc. (KYMR)
SEC 8-K
Current2024-03-28–present
-
Current
2024-03-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Kymera Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Jeremy Chadwick, Ph.D. COO
- Brian R. Adams General Counsel
- Brian R. Adams, J.D. General Counsel
- Brian Adams Board Member
- Bruce Booth Board Member
- Bruce Jacobs Board Member
- Elena Ridloff Board Member
- Gorjan Hrustanovic, Ph.D. Board Member
- Jared Gollob Board Member
- Jeremy Chadwick Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.